Globus Medical (GMED) awards 40,000 long-term stock options to EVP

Rhea-AI Filing Summary

Globus Medical Inc. reported that executive Kelly G. Huller, EVP, General Counsel and Corporate Secretary, received a grant of stock options on January 21, 2026. The award covers 40,000 stock options to buy Class A common stock at an exercise price of $94.15 per share, with the options held directly.

According to the vesting terms, the options vest over four years, with 25% vesting on January 1, 2027, and the remaining options vesting in equal monthly installments of 1/48 each month thereafter. The options have an expiration date of January 21, 2036, giving the executive a long-term incentive tied to the company’s share performance.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Huller Kelly

Role EVP, GC, Corporate Secretary

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy Class A Common Stock)	40,000	$0.00	--

Holdings After Transaction: Stock Option (Right to Buy Class A Common Stock) — 40,000 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Huller Kelly

(Last) (First) (Middle)

VALLEY FORGE BUSINESS CENTER

2560 GENERAL ARMISTEAD AVENUE

(Street)

AUDUBON PA 19403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GLOBUS MEDICAL INC [ GMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, GC, Corporate Secretary

3. Date of Earliest Transaction (Month/Day/Year)
01/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy Class A Common Stock)	$94.15	01/21/2026		A		40,000		(1)	01/21/2036	Class A Common Stock	40,000	$0	40,000	D

Explanation of Responses:

1. These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter.

	/s/ Kelly G. Huller	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did GMED report for Kelly G. Huller?

GMED reported that Kelly G. Huller, EVP, General Counsel and Corporate Secretary, received a grant of 40,000 stock options on January 21, 2026.

How many Globus Medical (GMED) stock options were granted to Kelly Huller?

The Form 4 shows a grant of 40,000 stock options to buy Class A common stock, all held under direct ownership.

What is the exercise price of Kelly Huller’s GMED stock options?

The options allow the purchase of Class A common stock at an exercise price of $94.15 per share.

How do Kelly Huller’s GMED stock options vest?

The options vest over four years: 1/4 vests on January 1, 2027, and the remaining 3/4 vest in equal monthly installments of 1/48 each month thereafter.

When do Kelly Huller’s Globus Medical stock options expire?

The options expire on January 21, 2036, as disclosed in the Form 4.

What position does Kelly G. Huller hold at Globus Medical (GMED)?

Kelly G. Huller is listed as an officer of Globus Medical with the title EVP, GC, Corporate Secretary.